A Safety and Tolerability Study of Jaktinib

NCT05279001 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: Jaktinib Hydrochloride Tablet

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd